BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17981731)

  • 1. HGF and c-MET as potential orchestrators of invasive growth in head and neck squamous cell carcinoma.
    De Herdt MJ; Baatenburg de Jong RJ
    Front Biosci; 2008 Jan; 13():2516-26. PubMed ID: 17981731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer.
    Knowles LM; Stabile LP; Egloff AM; Rothstein ME; Thomas SM; Gubish CT; Lerner EC; Seethala RR; Suzuki S; Quesnelle KM; Morgan S; Ferris RL; Grandis JR; Siegfried JM
    Clin Cancer Res; 2009 Jun; 15(11):3740-50. PubMed ID: 19470725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
    Lim YC; Kang HJ; Moon JH
    Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of the HGF/Met signaling in head and neck squamous cell carcinoma: Focus on tumor immunity (Review).
    Liu D; Zhong M; Zhan D; Zhang Y; Liu S
    Oncol Rep; 2020 Dec; 44(6):2337-2344. PubMed ID: 33125120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of Met Receptor Level on HGF-Induced Glycolytic Reprogramming in Head and Neck Squamous Cell Carcinoma.
    Boschert V; Klenk N; Abt A; Janaki Raman S; Fischer M; Brands RC; Seher A; Linz C; Müller-Richter UDA; Bischler T; Hartmann S
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31940827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment.
    Hartmann S; Bhola NE; Grandis JR
    Clin Cancer Res; 2016 Aug; 22(16):4005-13. PubMed ID: 27370607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
    Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer.
    Raj S; Kesari KK; Kumar A; Rathi B; Sharma A; Gupta PK; Jha SK; Jha NK; Slama P; Roychoudhury S; Kumar D
    Mol Cancer; 2022 Jan; 21(1):31. PubMed ID: 35081970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of microRNA expression by hepatocyte growth factor in human head and neck squamous cell carcinoma.
    Susuki D; Kimura S; Naganuma S; Tsuchiyama K; Tanaka T; Kitamura N; Fujieda S; Itoh H
    Cancer Sci; 2011 Dec; 102(12):2164-71. PubMed ID: 21899661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
    Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
    Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-type Protein tyrosine phosphatase β regulates met phosphorylation and function in head and neck squamous cell carcinoma.
    Xu Y; Zhou J; Carey TE; McHugh JB; Voorhees JJ; Fisher GJ
    Neoplasia; 2012 Nov; 14(11):1015-22. PubMed ID: 23226095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N
    J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic target for head and neck squamous cell carcinoma: HGF-MET signaling pathway.
    Lau PC; Chan AT
    Anticancer Drugs; 2011 Aug; 22(7):665-73. PubMed ID: 21709616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B.
    Zeng Q; Chen S; You Z; Yang F; Carey TE; Saims D; Wang CY
    J Biol Chem; 2002 Jul; 277(28):25203-8. PubMed ID: 11994287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2. Implication in head and neck squamous cell carcinoma progression.
    Zeng Q; McCauley LK; Wang CY
    J Biol Chem; 2002 Dec; 277(51):50137-42. PubMed ID: 12393863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
    Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
    Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bitter melon reduces head and neck squamous cell carcinoma growth by targeting c-Met signaling.
    Rajamoorthi A; Shrivastava S; Steele R; Nerurkar P; Gonzalez JG; Crawford S; Varvares M; Ray RB
    PLoS One; 2013; 8(10):e78006. PubMed ID: 24147107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head neck squamous cell carcinoma c-Met⁺ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis.
    Sun S; Wang Z
    Int J Cancer; 2011 Nov; 129(10):2337-48. PubMed ID: 21225626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression.
    Kumar D; New J; Vishwakarma V; Joshi R; Enders J; Lin F; Dasari S; Gutierrez WR; Leef G; Ponnurangam S; Chavan H; Ganaden L; Thornton MM; Dai H; Tawfik O; Straub J; Shnayder Y; Kakarala K; Tsue TT; Girod DA; Van Houten B; Anant S; Krishnamurthy P; Thomas SM
    Cancer Res; 2018 Jul; 78(14):3769-3782. PubMed ID: 29769197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma.
    Lai JP; Chien J; Strome SE; Staub J; Montoya DP; Greene EL; Smith DI; Roberts LR; Shridhar V
    Oncogene; 2004 Feb; 23(7):1439-47. PubMed ID: 14973553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.